Last reviewed · How we verify

NCT05187299

Use of an Observer Tool to Improve Learning Outcomes for Cardiac Arrest Management

Status unknown NA Last updated 11 January 2022
What this trial tests

NA trial testing observer tool in Simulation in 120 participants. Status unknown.

Timeline
10 January 2022
Primary endpoint
20 January 2022
31 December 2022

Quick facts

Lead sponsorUniversité Paris-Sud
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment120
Start date10 January 2022
Primary completion20 January 2022
Estimated completion31 December 2022

Drugs / interventions tested

Conditions studied

Sponsor

Université Paris-Sud

Who can join

Adults 18 to 50, any sex, with Simulation or Education. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Only approximately 10.4% of patients with out-of-hospital cardiac arrest (OHCA) survive their initial hospitalization. The very early management of cardiac arrest is indeed considered an extremely important criterion to improve patients' outcome. Despite recent advances and improved results, outcomes remain poor, especially because bystanders are not well trained to manage such a crisis situation. According to the International Liaison Committee on Resuscitation, teaching and learning the knowledge, skills and attitudes of resuscitation with the ultimate aim of improving patient survival after cardiac arrest is thus an essential goal. Teaching and learning strategies are numerous and have been well described and reviewed recently. Considering initial training methods already requires attention as study results often fail to show complete and effective learning after the initial training. Educational efficiency may be improved by several means (for example use of digital media) but it is now clear that more effective training strategies, i.e. those focusing on the cognitive process which leads to inclusion in memory), are needed. One recently introduced strategy, mainly in the field of simulation, is the use of observer tools. It has been shown that although effectiveness was still poorly demonstrated, this method had the potential to improve learning outcomes. An observer tool is a document which is used by observers during a scenario played by other learners and immediately compares the player's technical or non-technical skills with a referential guide. As it has been shown that observers learn less than those on the "hot seat" and as time for training is limited and the number of trainees is huge, focusing on observers is important. By visually assessing the practice of others repeatedly during the course and comparing each performance to the reference (i.e. the observer tool), the learner may increase his engagement in the training process with an expected final result of improved training efficacy. In a previous study performed in our simulation center, it has been have shown that using an observer tool increases immediate learning scores during operating room crisis management simulation. Good data on the use of such an observer tool in other training fields is needed to confirm these preliminary positive results.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. An observer tool to enhance learning of medical students during simulation training of cardiopulmonary resuscitation: a randomised controlled trial.
    Goulamhoussen A, Havard C, Gille B, François B, et al · · 2024 · cited 2× · PMID 38961381 · DOI 10.1186/s12909-024-05658-x

Verify or expand the search:

Other trials of observer tool

Trials testing the same drug.

Other recruiting trials for Simulation

Currently open trials in the same condition.

Other Université Paris-Sud trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05187299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing